CARMIEL, Israel , Dec. 23, 2024 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE-American: PLX), a biophar

Application to label a less frequent dosing regimen at a dose of 2 mg/kg body weight administered every four w

Company to host conference call and webcast today at 8:30 a.m. EST CARMIEL, Israel , Nov. 14, 2024 /PRNewswire